The Valvular Interventions Center

Filter Your Results

 

News

 

Clinical Feasibility Study Begins for Colibri's Second-Generation TAVR System

March 19, 2018 -- Colibri Heart Valve LLC announced that the first two patients have been enrolled in a clinical early feasibility study of the company’s second-generati…

Japan Approves National Reimbursement for Abbott's MitraClip

March 19, 2018 -- Abbott Structural Heart announced that the Ministry of Health, Labor, and Welfare in Japan granted national reimbursement for the company's MitraCli…

Five-Year Data From NOTION and Extreme-Risk Trials Presented for Medtronic's CoreValve TAVR Systems

March 10, 2018 -- Medtronic announced that outcomes from the real-world Nordic Aortic Valve Intervention Trial (NOTION) and the CoreValve United States Pivotal Extreme Risk St…

Abbott's Masters HP 15-mm Pediatric Heart Valve Approved by FDA

March 8, 2018 -- Abbott announced that the US Food and Drug Administration (FDA) approved its Masters HP 15-mm rotatable mechanical heart valve, which will allow doctors to tr…

Early and Newer-Generation TAVR Devices Compared in Patients With Native Aortic Valve Regurgitation

March 5, 2018 -- Danny Dvir, MD, presented the results of a trial investigating transcatheter aortic valve replacement (TAVR) for the treatment of pure native aortic valve reg…

Early Results Presented for Edwards' Sapien M3 System to Treat Mitral Regurgitation

March 5, 2018 -- John Webb, MD, presented "encouraging" findings from the early experience with the Sapien M3 system (Edwards Lifesciences) for the treatment of mitr…

REAC-TAVI Evaluates Ticagrelor to Suppress Platelet Reactivity After TAVR

March 5, 2018 -- Ticagrelor is more effective than clopidogrel at suppressing high platelet reactivity after transcatheter aortic valve replacement (TAVR) in patients with sev…

Early Results Presented From Low-Risk TAVR Study

March 5, 2018 -- Ron Waksman, MD, presented an interim analysis of a study assessing the safety and feasibility of transcatheter aortic valve replacement (TAVR) with commercia…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.